pQCXIH-Myc-YAP-S94A Citations (10)
Originally described in: Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control.Zhao B, Wei X, Li W, Udan RS, Yang Q, Kim J, Xie J, Ikenoue T, Yu J, Li L, Zheng P, Ye K, Chinnaiyan A, Halder G, Lai ZC, Guan KL Genes Dev. 2007 Nov 1. 21(21):2747-61. PubMed Journal
Articles Citing pQCXIH-Myc-YAP-S94A
| Articles |
|---|
| YAP/TAZ enhance mammalian embryonic neural stem cell characteristics in a Tead-dependent manner. Han D, Byun SH, Park S, Kim J, Kim I, Ha S, Kwon M, Yoon K. Biochem Biophys Res Commun. 2015 Feb 27;458(1):110-6. doi: 10.1016/j.bbrc.2015.01.077. Epub 2015 Jan 26. PubMed |
| Sox2 antagonizes the Hippo pathway to maintain stemness in cancer cells. Basu-Roy U, Bayin NS, Rattanakorn K, Han E, Placantonakis DG, Mansukhani A, Basilico C. Nat Commun. 2015 Apr 2;6:6411. doi: 10.1038/ncomms7411. PubMed |
| Angiomotin stabilization by tankyrase inhibitors antagonizes constitutive TEAD-dependent transcription and proliferation of human tumor cells with Hippo pathway core component mutations. Troilo A, Benson EK, Esposito D, Garibsingh RA, Reddy EP, Mungamuri SK, Aaronson SA. Oncotarget. 2016 Apr 29. doi: 10.18632/oncotarget.9117. PubMed |
Pericyte-like spreading by disseminated cancer cells activates YAP and MRTF for metastatic colonization.
Er EE, Valiente M, Ganesh K, Zou Y, Agrawal S, Hu J, Griscom B, Rosenblum M, Boire A, Brogi E, Giancotti FG, Schachner M, Malladi S, Massague J.
Nat Cell Biol. 2018 Aug;20(8):966-978. doi: 10.1038/s41556-018-0138-8. Epub 2018 Jul 23.
PubMed
Associated Plasmids |
| YAP promotes ocular neovascularization by modifying PFKFB3-driven endothelial glycolysis. Feng Y, Zou R, Zhang X, Shen M, Chen X, Wang J, Niu W, Yuan Y, Yuan F. Angiogenesis. 2021 Jan 5. pii: 10.1007/s10456-020-09760-8. doi: 10.1007/s10456-020-09760-8. PubMed |
| Involvement of the TGF-beta Signaling Pathway in the Development of YAP-Driven Osteosarcoma Lung Metastasis. Morice S, Danieau G, Tesfaye R, Mullard M, Brion R, Dupuy M, Ory B, Brounais-Le Royer B, Corre I, Redini F, Verrecchia F. Front Oncol. 2021 Oct 26;11:765711. doi: 10.3389/fonc.2021.765711. eCollection 2021. PubMed |
| Human blastoids model blastocyst development and implantation. Kagawa H, Javali A, Khoei HH, Sommer TM, Sestini G, Novatchkova M, Scholte Op Reimer Y, Castel G, Bruneau A, Maenhoudt N, Lammers J, Loubersac S, Freour T, Vankelecom H, David L, Rivron N. Nature. 2022 Jan;601(7894):600-605. doi: 10.1038/s41586-021-04267-8. Epub 2021 Dec 2. PubMed |
YAP1 activation by human papillomavirus E7 promotes basal cell identity in squamous epithelia.
Hatterschide J, Castagnino P, Kim HW, Sperry SM, Montone KT, Basu D, White EA.
Elife. 2022 Feb 16;11. pii: 75466. doi: 10.7554/eLife.75466.
PubMed
Associated Plasmids |
| YAP regulates an SGK1/mTORC1/SREBP-dependent lipogenic program to support proliferation and tissue growth. Vaidyanathan S, Salmi TM, Sathiqu RM, McConville MJ, Cox AG, Brown KK. Dev Cell. 2022 Mar 28;57(6):719-731.e8. doi: 10.1016/j.devcel.2022.02.004. Epub 2022 Feb 24. PubMed |
| Yap governs a lineage-specific neuregulin1 pathway-driven adaptive resistance to RAF kinase inhibitors. Garcia-Rendueles MER, Krishnamoorthy G, Saqcena M, Acuna-Ruiz A, Revilla G, de Stanchina E, Knauf JA, Lester R, Xu B, Ghossein RA, Fagin JA. Mol Cancer. 2022 Dec 7;21(1):213. doi: 10.1186/s12943-022-01676-9. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.